Metformin in Gestational Diabetes: The Offspring Follow-Up (MiG TOFU)
Janet Rowan(Auckland City Hospital), William M. Hague(University of Adelaide), Elaine Rush(Auckland University of Technology), Malcolm Battin(University of Auckland), Trecia A. Wouldes(University of Auckland), Victor Obolonkin(University of Auckland)
Cited by 385
Related Papers
Metformin versus Insulin for the Treatment of Gestational Diabetes
|New England Journal of Medicine|2008|1.3k
Metformin in gestational diabetes: the offspring follow-up (MiG TOFU): body composition and metabolic outcomes at 7–9 years of age
|BMJ Open Diabetes Research & Care|2018|295
An Early Pregnancy HbA1c ≥5.9% (41 mmol/mol) Is Optimal for Detecting Diabetes and Identifies Women at Increased Risk of Adverse Pregnancy Outcomes
|Diabetes Care|2014|239
Neurodevelopmental outcome at 2 years in offspring of women randomised to metformin or insulin treatment for gestational diabetes
|Archives of Disease in Childhood Fetal & Neonatal|2016|109
Is There a Role for HbA1c in Pregnancy?
|Current Diabetes Reports|2016|107